$LUCY
Innovative Eyewear Inc Stock $lucy

$lucy Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000182912624007427 Filed on November 12, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$253.6K
YoY Change		14.3%
Cost Of Revenue		$194.3K
YoY Change		37.25%
Gross Profit		$59.34K
YoY Change		-26.14%
Gross Profit Margin		23.4%
Selling, General & Admin		$1.655M
YoY Change		14.18%
% of Gross Profit		2788.89%
Research & Development		$131.4K
YoY Change		-31.83%
% of Gross Profit		221.37%
Depreciation & Amortization		$23.96K
YoY Change		40.78%
% of Gross Profit		40.37%
Operating Expenses		$1.821M
YoY Change		8.6%
Operating Profit		-$1.762M
YoY Change		10.35%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$41.39K
YoY Change		-9.42%
Pretax Income		-$1.721M
YoY Change		10.93%
Income Tax		$0.00
% Of Pretax Income
Net Earnings		-$1.721M
YoY Change		10.93%
Net Earnings / Revenue		-678.5%
Basic Earnings Per Share		-$0.99
Diluted Earnings Per Share		-$0.99
COMMON SHARES
Basic Shares Outstanding	2.442M shares	1.571M shares
Diluted Shares Outstanding		1.737M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$9.439M
YoY Change		61.27%
Cash & Equivalents		$4.544M
Short-Term Investments		$4.895M
Other Short-Term Assets		$59.45K
YoY Change		14.7%
Inventory		$915.2K
Prepaid Expenses		$324.8K
Receivables		$80.89K
Other Receivables		$0.00
Total Short-Term Assets		$10.99M
YoY Change		46.54%
LONG-TERM ASSETS
Property, Plant & Equipment		$106.7K
YoY Change		-40.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$66.97K
YoY Change		23.77%
Total Long-Term Assets		$604.7K
YoY Change		-1.66%
TOTAL ASSETS
Total Short-Term Assets		$10.99M
Total Long-Term Assets		$604.7K
Total Assets		$11.60M
YoY Change		42.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$608.0K
YoY Change		226.94%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$653.0K
YoY Change		51.44%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$12.95K
YoY Change		-69.53%
Total Long-Term Liabilities		$12.95K
YoY Change		-69.53%
TOTAL LIABILITIES
Total Short-Term Liabilities		$653.0K
Total Long-Term Liabilities		$12.95K
Total Liabilities		$665.9K
YoY Change		40.58%
SHAREHOLDERS EQUITY
Retained Earnings		-$22.61M
YoY Change		55.12%
Common Stock		$24.00
YoY Change		-81.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$10.93M
YoY Change
Total Liabilities & Shareholders Equity		$11.60M
YoY Change		42.89%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$1.721M
YoY Change		10.93%
Depreciation, Depletion And Amortization		$23.96K
YoY Change		40.78%
Cash From Operating Activities		-$1.400M
YoY Change		2.89%
INVESTING ACTIVITIES
Capital Expenditures		$91.74K
YoY Change		2.54%
Acquisitions
YoY Change
Other Investing Activities		-$4.895M
YoY Change		-611997.5%
Cash From Investing Activities		-$4.987M
YoY Change		5523.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		5.034M
YoY Change		322562.82%
NET CHANGE
Cash From Operating Activities		-1.400M
Cash From Investing Activities		-4.987M
Cash From Financing Activities		5.034M
Net Change In Cash		-1.353M
YoY Change		-6.52%
FREE CASH FLOW
Cash From Operating Activities		-$1.400M
Capital Expenditures		$91.74K
Free Cash Flow		-$1.491M
YoY Change		2.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity File Number EntityFileNumber	001-41392
	dei	Entity Registrant Name EntityRegistrantName	INNOVATIVE EYEWEAR, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33181
	dei	City Area Code CityAreaCode	954
	dei	Local Phone Number LocalPhoneNumber	826-0329
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1677140	usd
	us-gaap	Operating Expenses OperatingExpenses	5872483	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001808377
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-0734861
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11900 Biscayne Blvd.
	dei	Entity Address City Or Town EntityAddressCityOrTown	North Miami
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2442248	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4543826	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4287447	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	313648	usd
CY2023Q4	LUCY	Inventory Prepayment InventoryPrepayment	323520	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	533239	usd
CY2023Q4	LUCY	Due From Tekcapital And Affiliates DueFromTekcapitalAndAffiliates	6256	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	59447	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5616768	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	286429	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	88073	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	154848	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	72644	usd
CY2023Q4	us-gaap	Assets Assets	6218762	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	581986	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	42500	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	624486	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	35450	usd
CY2023Q4	us-gaap	Liabilities Liabilities	659936	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16969415	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5558826	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6218762	usd
CY2023Q3	us-gaap	Revenues Revenues	221875	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited		shares
CY2024Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited		shares
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	652963	usd
CY2024Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	12950	usd
CY2024Q3	us-gaap	Liabilities Liabilities	665913	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2420934	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2420934	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	747416	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	747416	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33540703	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22528234	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	10930925	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11596838	usd
CY2024Q3	us-gaap	Revenues Revenues	253599	usd
	us-gaap	Revenues Revenues	945752	usd
	us-gaap	Revenues Revenues	536725	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	194255	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	141531	usd
	us-gaap	Cost Of Revenue CostOfRevenue	824281	usd
	us-gaap	Cost Of Revenue CostOfRevenue	475906	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	59344	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	80344	usd
	us-gaap	Gross Profit GrossProfit	121471	usd
	us-gaap	Gross Profit GrossProfit	60819	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1121972	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	915537	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3526217	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2877663	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	533066	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	533902	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1636794	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	896842	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	131369	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	192701	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	604472	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	541348	usd
CY2024Q3	us-gaap	Management Fee Expense ManagementFeeExpense	35000	usd
CY2023Q3	us-gaap	Management Fee Expense ManagementFeeExpense	35000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	105000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	105000	usd
	us-gaap	Operating Expenses OperatingExpenses	4420853	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	41386	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	45691	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	110625	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	93353	usd
	us-gaap	Interest Expense InterestExpense	3036	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	41386	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	45691	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	110625	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	90317	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1720677	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1551105	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5640387	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4269717	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1736803	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1736803	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	747416	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	747416	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1178768	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1178768	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	586807	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.99
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.99
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.08
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.78
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.28
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5558826	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	81900	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	232154	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1971311	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	3901569	usd
CY2024Q2	LUCY	Atthemarket Offerings AtthemarketOfferings	2324579	usd
CY2024Q2	LUCY	First Registered Direct Offering FirstRegisteredDirectOffering	737300	usd
CY2024Q2	LUCY	Second Registered Direct Offering SecondRegisteredDirectOffering	2134051	usd
CY2024Q2	LUCY	Issuance Of Shares To Brand Ambassador IssuanceOfSharesToBrandAmbassador	21690	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	173305	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1948399	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7344095	usd
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q4	us-gaap	Debt Securities Current DebtSecuritiesCurrent		usd
CY2024Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet		usd
CY2023Q3	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions		usd
	LUCY	Loan Made To Tekcapital Europe Ltd.See Note6 LoanMadeToTekcapitalEuropeLtd.SeeNote6		usd
	LUCY	Repayment Of Amounts Loaned To Tekcapital Europe Ltd.See Note6 RepaymentOfAmountsLoanedToTekcapitalEuropeLtd.SeeNote6		usd
	LUCY	Proceeds From Atthemarket Offerings Of Common Stock ProceedsFromAtthemarketOfferingsOfCommonStock		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	LUCY	Issuance Of Shares From Conversion Of Related Party Convertible Debt IssuanceOfSharesFromConversionOfRelatedPartyConvertibleDebt		usd
	LUCY	Issuance Of Shares For Prepayment To Brand Ambassador IssuanceOfSharesForPrepaymentToBrandAmbassador		usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths		usd
	LUCY	Stock Issued During Period Shares Stock Option Exercised StockIssuedDuringPeriodSharesStockOptionExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 630
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	us-gaap	Debt Securities Current DebtSecuritiesCurrent	4895184	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	80887	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	93211	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	324775	usd
CY2024Q3	LUCY	Inventory Prepayment InventoryPrepayment	139065	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	915185	usd
CY2024Q3	LUCY	Due From Tekcapital And Affiliates DueFromTekcapitalAndAffiliates	33774	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	59447	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	10992143	usd
CY2024Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	431034	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106689	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	66972	usd
CY2024Q3	us-gaap	Assets Assets	11596838	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	607950	usd
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	45013	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	24	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22609802	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	1821407	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	586807	shares
CY2024Q3	LUCY	Atthemarket Offerings AtthemarketOfferings	1398555	usd
CY2024Q3	LUCY	Exercises Of Warrants Related To Inducement Agreements ExercisesOfWarrantsRelatedToInducementAgreements	3503879	usd
CY2024Q3	LUCY	Exercises Of Warrants ExercisesOfWarrants	299998	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	105075	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-1720677	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	10930925	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4024429	usd
CY2023Q1	LUCY	Exercises Of Warrants By Stockholders ExercisesOfWarrantsByStockholders	1532250	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	424431	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1430810	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4550300	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	17650	usd
CY2023Q2	LUCY	Exercises Of Warrants By Stockholders ExercisesOfWarrantsByStockholders	1204200	usd
CY2023Q2	LUCY	Exercises Of Warrants Related To Private Placement Transaction ExercisesOfWarrantsRelatedToPrivatePlacementTransaction	391268	usd
CY2023Q2	LUCY	Second Public Offering SecondPublicOffering	4115688	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-40180	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1287802	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	8951124	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	242235	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-1551105	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7642254	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5640387	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4269717	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	83907	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45996	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25199	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20030	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	3036	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	510534	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	626486	usd
	LUCY	Expenses Paid By Parent And Affiliates ExpensesPaidByParentAndAffiliates	217368	usd
	LUCY	Expenses Paid By Parent And Affiliates ExpensesPaidByParentAndAffiliates	222459	usd
	LUCY	Recovery Of Provision For Doubtful Accounts RecoveryOfProvisionForDoubtfulAccounts	-2605	usd
	LUCY	Recovery Of Provision For Doubtful Accounts RecoveryOfProvisionForDoubtfulAccounts	-25121	usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	88073	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-37429	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7760	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	25964	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-92745	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-47740	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	79618	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	197491	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	885940	usd
	LUCY	Contract Assets And Liabilities ContractAssetsAndLiabilities	-7908	usd
	LUCY	Contract Assets And Liabilities ContractAssetsAndLiabilities	-2080	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4796361	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4425294	usd
	LUCY	Purchases Of Debt Securities PurchasesOfDebtSecurities	4895184	usd
	LUCY	Purchases Of Debt Securities PurchasesOfDebtSecurities	1949204	usd
	LUCY	Loan Made To Tekcapital Europe Ltd.See Note6 LoanMadeToTekcapitalEuropeLtd.SeeNote6	767940	usd
	LUCY	Repayment Of Amounts Loaned To Tekcapital Europe Ltd.See Note6 RepaymentOfAmountsLoanedToTekcapitalEuropeLtd.SeeNote6	-767940	usd
	LUCY	Payment To Acquire Patent Costs PaymentToAcquirePatentCosts	169804	usd
	LUCY	Payment To Acquire Patent Costs PaymentToAcquirePatentCosts	154752	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35748	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	104722	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5100736	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2208678	usd
	LUCY	Proceeds From Offerings Of Common Stock And Warrants ProceedsFromOfferingsOfCommonStockAndWarrants	2871351	usd
	LUCY	Proceeds From Offerings Of Common Stock And Warrants ProceedsFromOfferingsOfCommonStockAndWarrants	4115688	usd
	LUCY	Proceeds From Atthemarket Offerings Of Common Stock ProceedsFromAtthemarketOfferingsOfCommonStock	3723134	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3803877	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3127718	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17650	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	109499	usd
	LUCY	Repayment Of Amounts Due To Tekcapital And Affiliates RepaymentOfAmountsDueToTekcapitalAndAffiliates	244886	usd
	LUCY	Repayment Of Amounts Due To Tekcapital And Affiliates RepaymentOfAmountsDueToTekcapitalAndAffiliates	205026	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10153476	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6946531	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	256379	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	312559	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4287447	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3591109	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4543826	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3903668	usd
	LUCY	Expenses Paid For By Parent Reported As Increase In Due To Parent And Affiliates And Related Party Convertible Debt ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt	217368	usd
	LUCY	Expenses Paid For By Parent Reported As Increase In Due To Parent And Affiliates And Related Party Convertible Debt ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt	222459	usd
	LUCY	Issuance Of Shares From Conversion Of Related Party Convertible Debt IssuanceOfSharesFromConversionOfRelatedPartyConvertibleDebt	81900	usd
	LUCY	Issuance Of Shares For Prepayment To Brand Ambassador IssuanceOfSharesForPrepaymentToBrandAmbassador	21690	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80A_eus-gaap--NatureOfOperations_zUdWN1ItN56j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1 – <span id="xdx_82C_z5YYmA3WYMfl">GENERAL INFORMATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd., a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, together with Lucyd Ltd., “Tekcapital and Affiliates”), which owned approximately 10.8% of our issued and outstanding shares of common stock as of September 30, 2024. Innovative Eyewear has licensed the exclusive rights to the Lucyd<sup>®</sup> brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte<sup>®</sup> glasses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zsBZfWecMpp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_865_z7gPtwKzNSYe">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	4895184	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6116	usd
	LUCY	Schedule Of Allowance For Doubtful Accounts Table Text Blok ScheduleOfAllowanceForDoubtfulAccountsTableTextBlok	<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfAllowanceForDoubtfulAccountsTableTextBlok_zrNnIk1HxdT2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="display: none"><span id="xdx_8B1_zvoORaNeXHzg">Schedule of allowance for doubtful accounts</span></span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 76%; vertical-align: top">Balance at January 1</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240101__20240930_zpGiJCUk4IOd" style="width: 9%; text-align: right" title="Balance at begining">25,772</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230101__20230930_zorhFVtMNNT5" style="width: 9%; text-align: right" title="Balance at begining">92,646</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Bad debt expense (recovery)</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_eus-gaap--ProvisionForDoubtfulAccounts_c20240101__20240930_pp0p0" style="text-align: right" title="Bad debt expense (recovery)">(2,605</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--ProvisionForDoubtfulAccounts_c20230101__20230930_pp0p0" style="text-align: right" title="Bad debt expense (recovery)">19,879</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Write-offs<sup>(1)</sup></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pp0p0_di_c20240101__20240930_fKDEp_zKnCmgpEgZr1" style="text-align: right" title="Write-offs"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pp0p0_di_c20230101__20230930_fKDEp_zRLwj2audPCl" style="text-align: right" title="Write-offs">(47,813</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; vertical-align: top; text-align: left">Other<sup>(1)</sup></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsReceivableOther_pp0p0_c20240101__20240930_fKDEp_z5usOhYbpGy1" style="border-bottom: Black 1pt solid; text-align: right" title="Other">218</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsReceivableOther_pp0p0_c20230101__20230930_fKDEp_zKDJibu1RhHi" style="border-bottom: Black 1pt solid; text-align: right" title="Other">(45,000</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; vertical-align: top; text-align: left">Balance at September 30</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240101__20240930_zcaWdseYEfW4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at end">23,385</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230101__20230930_zhLXRia7Npx5" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at end">19,712</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td> <td id="xdx_F0F_zHgwjIVqBfwc" style="width: 0.25in; text-align: left">(1)</td> <td id="xdx_F19_zlyynrf8f3Y7" style="text-align: justify">During the nine months ended September 30, 2023, the Company entered into a settlement agreement with a former wholesale customer. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the condensed statement of operations.</td> </tr> </table>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25772	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	92646	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-2605	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	19879	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	47813	usd
	LUCY	Allowance For Doubtful Accounts Receivable Other AllowanceForDoubtfulAccountsReceivableOther	218	usd
	LUCY	Allowance For Doubtful Accounts Receivable Other AllowanceForDoubtfulAccountsReceivableOther	-45000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	23385	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	19712	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	31637	usd
CY2024Q3	LUCY	Inventory Prepayment InventoryPrepayment	139065	usd
CY2023Q4	LUCY	Inventory Prepayment InventoryPrepayment	323520	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	22500	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	22500	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2513	usd
CY2024Q1	LUCY	Restocking Fee RestockingFee	15	usd
CY2024Q3	LUCY	Allowance For Sales Returns AllowanceForSalesReturns	5302	usd
CY2023Q4	LUCY	Allowance For Sales Returns AllowanceForSalesReturns	40933	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	271573	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	235825	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	164884	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	80977	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106689	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	154848	usd
CY2024Q3	us-gaap	Depreciation Depreciation	23956	usd
CY2023Q3	us-gaap	Depreciation Depreciation	17017	usd
	us-gaap	Depreciation Depreciation	83907	usd
	us-gaap	Depreciation Depreciation	45996	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	499036	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	329232	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	68002	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	42803	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	431034	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	286429	usd
CY2024Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	9902	usd
CY2023Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2214	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	25199	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20030	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	61356	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	48143	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	436000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	834000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1290000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1543000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	9907000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14010000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	144726	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	41.60
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M19D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.40
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	50426	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	42.13
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	94800	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	41.15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y3M18D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	64816	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	52.60
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y7M9D
CY2024Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	100000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	495309	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	193000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y1M6D
CY2024Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	5075	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	15225	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	3383	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	81900	usd
CY2024Q3	LUCY	Stock Grants Expenses StockGrantsExpenses	40950	usd
	LUCY	Stock Grants Expenses StockGrantsExpenses	81900	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2828	shares
CY2024Q2	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	13000	usd
CY2024Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	12000	usd
CY2024Q3	LUCY	Description Of Warrant Exercise DescriptionOfWarrantExercise	one of the holders of the Series A and Series B warrants exercised an aggregate of 40,000 warrants on a cashless basis and received 20,482 shares of common stock.
CY2024Q3	LUCY	Description Of Warrant Exercise DescriptionOfWarrantExercise	one of the holders of the warrants issued in connection with the First Registered Direct Offering elected to exercise their warrants to purchase an aggregate of 61,475 shares of common stock. The Company received approximately $300,000 of gross proceeds from this exercise.
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1569840	shares
	LUCY	Release Payment ReleasePayment	325000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1720677	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1551105	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5640387	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4269717	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1736803	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1736803	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	747416	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	747416	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1178768	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1178768	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	586807	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	586807	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.99
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.99
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.08
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.78
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.28
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
lucy-20240930_lab.xml	Edgar Link	unprocessable
0001829126-24-007427-index-headers.html	Edgar Link	pending
0001829126-24-007427-index.html	Edgar Link	pending
0001829126-24-007427.txt	Edgar Link	pending
0001829126-24-007427-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img_001.jpg	Edgar Link	pending
innovative_10q.htm	Edgar Link	pending
innovative_ex31-1.htm	Edgar Link	pending
innovative_ex31-2.htm	Edgar Link	pending
innovative_ex32-1.htm	Edgar Link	pending
innovative_ex32-2.htm	Edgar Link	pending
lucy-20240930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lucy-20240930_cal.xml	Edgar Link	unprocessable
lucy-20240930_def.xml	Edgar Link	unprocessable
innovative_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lucy-20240930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUCY
Innovative Eyewear Inc Stock $lucy

2024 Q4 Form 10-Q Financial Statement

#000182912624007427 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCY Innovative Eyewear Inc Stock $lucy

2024 Q4 Form 10-Q Financial Statement

#000182912624007427 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCY
Innovative Eyewear Inc Stock $lucy